Bisphenol A: FDA Analysis Mistakes and Redesign Opportunities

Wonder how FDA concluded BPA levels in people were too low to matter? False assumptions and circular logic…

  • Where the FDA went wrong
  • Risks of using existing substitutes
  • Designing endocrine disruption out of new chemicals
More information

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s